Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
About us Powens is the trusted Open Finance partner for financial institutions and fast-growing companies across Europe and Latin America, helping them automate financial workflows, embed payments seamlessly, and turn real-time financial data into actionable decisions.
Crédit Agricole Personal Finance & Mobility, a wholly-owned subsidiary of the Crédit Agricole Group, specializes in financing solutions for individuals and provides access to all mobility solutions across Europe. It distributes, directly or through its partners,